Por: The Hill Health March 03, 2023
The vaccine company Novavax, which manufactures COVID-19 vaccines, says it has “substantial doubts” about its own ability to stay in business long term. Novavax said its current cash flow forecast should support short-term operations, but “significant uncertainty” about 2023 revenue, U.S. government funding and ongoing arbitration are jeopardizing the company’s outlook in the future. . Novavax stocks after its report announced the... + full article
The Hill USA Health February 14, 2023
The federal government has modified its existing contract with the American biotechnology company Novavax to purchase 1.5 million more doses of its COVID-19 vaccines. The Biden administration purchased 3.2 million doses of Novavax’s protein-based coronavirus vaccine in July... + más
FDA Authorizes Novavax's Covid Shots as Mix-And-Match Booster to Pfizer Or Moderna | NBC 6 South Florida
FDA authorizes Novavax's Covid shots as mix-and-match booster to Pfizer or Moderna | CNBC
CNBC USA Health November 09, 2022
In this articleIn this photo illustration a silhouette of a man holding a medical syringe and a vial seen displayed in front of the Novavax logo on a screen.Cezary Kowalski Lightrocket Getty ImagesNovavax posted an unexpected loss on Thursday but beat Wall Street's revenue... + más
Forbes USA Tech October 22, 2022
The U.S. Food and Drug Administration (FDA) has just extended the emergency use authorization (EUA) ... [+] for Novavax’s adjuvanted (NVX-CoV2373) Covid-19 vaccine to now include a first booster dose for those 18 years and older. (Photo by Matt McClain/The Washington Post via... + más
Los Angeles Times USA Science October 20, 2022
U.S. regulators on Wednesday authorized a booster dose of the COVID-19 vaccine made by Novavax. The Food and Drug Administration said the new booster option is for people 18 and older who can’t get the Omicron-targeting boosters from Pfizer-BioNTech or Moderna for medical or... + más
CNBC USA Health October 19, 2022
In this articleA healthcare worker prepares a dose of the Novavax Covid-19 vaccine at a pharmacy in Schwenksville, Pennsylvania, US, on Monday, Aug. 1, 2022.Hannah Beier Bloomberg Getty ImagesThe Food and Drug Administration has authorized 's Covid boosters for adults in... + más
Moderna vs. Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | PennLive
CNN USA Health October 19, 2022
CNN — The US Food and Drug Administration on Wednesday among adults 18 and older, at least six months after completing a primary Covid-19 vaccine series. The company announced that it has received emergency use authorization to provide a first booster dose of its vaccine... + más
US clears Novavax COVID booster dose | ABC News
NBC 6 South Florida USA World October 19, 2022
Hannah Beier Bloomberg Getty Images The Food and Drug Administration has authorized 's Covid boosters for adults in the U.S., including for people who received Pfizer's or Moderna's shots as their primary series. The authorization of Novavax's booster could... + más
About iurex | Privacy Policy | Disclaimer |